
Keywords: پلی ADA ریبوز پلی مراز; ALP; alkaline phosphatase; BMPs; bone morphogenetic proteins; C/EBPÃ; CCAAT/enhancer binding protein beta; CIA; collagen II induced arthritis; CTD; C-terminal domain; Cx43; connexin43; Cxs; connexins; DMOADs; disease-modifying osteoarthritis drugs; ECM;